AVXL News - Candlesense

Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025

(NASDAQ:AVXL) NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing ...

Investor event

5 days ago

Read more globenewswire

Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Established Precise Autophagy Mechanism with Blarcamesine

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative trea...

Research

12 days ago

Read more globenewswire

Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease

Pre-Treatment with blarcamesine entirely prevented Abeta-induced cognitive decline

Clinical trials

18 days ago

Read more globenewswire

Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update

Company to host a webcast today at 8:30 a.m. Eastern Time

What is the expected impact of any changes in the capital structure, such as stock issuances or debt financing, on dilution and shareholder value? Did the company announce any strategic partnerships, collaborations, or licensing deals that could materially affect its competitive position? What potential regulatory or reimbursement risks were highlighted that could affect future earnings?

Earnings

26 days ago

Read more globenewswire

ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Long-Term Investors to Contact the Firm

PHILADELPHIA, June 16, 2025 (GLOBE NEWSWIRE) -- The law firm of Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Anavex Life Sciences Corp. ...

Lawsuits

3 months ago

Read more globenewswire